JPMorgan analyst Ryan Brinkman raised the firm’s price target on Aptiv to $123 from $120 and keeps a Neutral rating on the shares. The analyst increased estimates to reflect the company’s Q2 beat and improved guidance.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on APTV:
